• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Evofem Biosciences Announces Financial Results for the First Quarter of 2023

    PR NEWSWIRE

    FDA Confirms Paragraph IV Patent Litigation for Lactic Acid, Citric Acid and Potassium Bitartrate

    FDA

    Evofem Biosciences receives US patent covering Phexxi composition of matter

    PHARMABIZ

    Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

    PRNEWSWIRE

    Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

    PRESS RELEASE

    Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

    PHARMAFILE

    Evofem Bio Announces Record Net Sales and Phexxi Prescriptions in Q4 2021

    PRNEWSWIRE

    "House Rules" Delivers Strong Initial Results and Drives Phexxi Growth

    PRNEWSWIRE

    Evofem Announces Launch of Phexx, First Non-Hormonal Contraceptive Vaginal Gel

    PRNEWSWIRE

    Evofem Announces Launch of Phexx,First Non-Hormonal Contraceptive Vaginal Gel

    PRNEWSWIRE

    Evofem Announces Peer-Reviewed Pub the Pivotal Ph3 AMPOWER Results For Phexxi™

    PRNEWSWIRE

    U.S. FDA Approves Evofem Biosciences` Phexxi™

    PRNEWSWIRE

    AMPHORA potassium bitartrate Receives "Qualified Infectious Disease Product

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.